The expression of TPP1 is developmentally controlled, reaching peak expression at 2–4 years of age, when the onset of signs and symptoms of late infantile neuronal ceroid lipofuscinosis (CLN2, LINCL) typically manifest [11]. This evidence concerns the gene TPP1 and infantile neuronal ceroid lipofuscinosis.